Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Amylyx Pharmaceuticals UK Limited
Amylyx Pharmaceuticals UK Limited is an active company incorporated on 29 March 2023 with the registered office located in London, City of London. Amylyx Pharmaceuticals UK Limited was registered 2 years 10 months ago.
Watch Company
Status
Active
Active since
incorporation
Company No
14766294
Private limited company
Age
2 years 10 months
Incorporated
29 March 2023
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
28 March 2025
(10 months ago)
Next confirmation dated
28 March 2026
Due by
11 April 2026
(2 months remaining)
Last change occurred
1 year 10 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Small
Next accounts for period
31 December 2025
Due by
30 September 2026
(8 months remaining)
Learn more about Amylyx Pharmaceuticals UK Limited
Contact
Update Details
Address
21 Holborn Viaduct
London
EC1A 2DY
United Kingdom
Same address since
incorporation
Companies in EC1A 2DY
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
2
Shareholders
1
Controllers (PSC)
1
James Matthew Frates
Director • Chief Financial Officer • American • Lives in United States • Born in Jun 1967
Thomas Joseph Holmes
Director • American • Lives in United States • Born in Mar 1969
Amylyx Pharmaceuticals, INC
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
No mutual companies found
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£3.67K
Decreased by £195.26K (-98%)
Turnover
£943.9K
Decreased by £175.82K (-16%)
Employees
4
Same as previous period
Total Assets
£25.2K
Decreased by £690.29K (-96%)
Total Liabilities
-£124.53K
Decreased by £628.34K (-83%)
Net Assets
-£99.32K
Decreased by £61.94K (+166%)
Debt Ratio (%)
494%
Increased by 388.87% (+370%)
See 10 Year Full Financials
Latest Activity
Small Accounts Submitted
1 Month Ago on 27 Dec 2025
Sisec Limited Resigned
1 Month Ago on 19 Dec 2025
Confirmation Submitted
10 Months Ago on 31 Mar 2025
Small Accounts Submitted
1 Year 1 Month Ago on 13 Dec 2024
James Matthew Frates Appointed
1 Year 8 Months Ago on 31 May 2024
Thomas Joseph Holmes Appointed
1 Year 8 Months Ago on 31 May 2024
Thomas Biet Resigned
1 Year 8 Months Ago on 31 May 2024
Stephanie Hoffmann Resigned
1 Year 8 Months Ago on 31 May 2024
Confirmation Submitted
1 Year 10 Months Ago on 28 Mar 2024
Accounting Period Shortened
2 Years 5 Months Ago on 7 Aug 2023
Get Alerts
Get Credit Report
Discover Amylyx Pharmaceuticals UK Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Accounts for a small company made up to 31 December 2024
Submitted on 27 Dec 2025
Termination of appointment of Sisec Limited as a secretary on 19 December 2025
Submitted on 19 Dec 2025
Confirmation statement made on 28 March 2025 with no updates
Submitted on 31 Mar 2025
Accounts for a small company made up to 31 December 2023
Submitted on 13 Dec 2024
Appointment of James Matthew Frates as a director on 31 May 2024
Submitted on 3 Jun 2024
Appointment of Thomas Joseph Holmes as a director on 31 May 2024
Submitted on 31 May 2024
Termination of appointment of Thomas Biet as a director on 31 May 2024
Submitted on 31 May 2024
Termination of appointment of Stephanie Hoffmann as a director on 31 May 2024
Submitted on 31 May 2024
Confirmation statement made on 28 March 2024 with updates
Submitted on 28 Mar 2024
Current accounting period shortened from 31 March 2024 to 31 December 2023
Submitted on 7 Aug 2023
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs